CARDEO NEURO PLEGIA

Brand Owner Address Description
CNP CARDEON CORPORATION 10161 Bubb Road Cupertino CA 95014 CARDEO NEURO PLEGIA;Cardiothoracic surgery devices and instruments, namely, catheters, introducers for placement of catheters, guidewires, occluders, probes, drug delivery catheters, percutaneous vascular access ports, syringes, tubing, pinch tubes, heart valve prostheses and holders for heart valve prostheses, forceps, graspers, porous balloons, knives, needle drivers, scalpels, staplers, scissors, sutures, electrocautery scalpels, cannulae, blood filters, external valves and internal valves for occluding the aorta, blood pressure monitoring apparatus, porous balloons, shunts, therapeutic catheters, stents, atherectomy catheters, aspirators, atrial isolators, perfusion catheters; neurology and neurosurgery devices, namely, instruments used in the treatment of stroke, ischemia, infarcts, and other diseases and injuries of the central and cerebral nervous system, namely, catheters, heat exchangers and blood pumps; cardiopulmonary support and perfusion devices and instruments, namely, extracorporeal pumps, oxygenators, heat exchangers, switches for changing the flow of blood, stroke treatment prevention devices and instruments namely, catheters, drug delivery catheters, introducers for placement of catheters, guidewires, occluders probes, percutaneous vascular access ports, tubing, trocars, heart valve prosthesis and holders for heart valve prostheses, retractors, forceps, graspers, knives, needle drivers, staplers, scalpels, scissors, sutures, electrocautery scalpels, cannulae, blood filters, external valves and internal valves for occluding the aorta, blood pressure monitoring apparatus, porous balloons, shunts, therapeutic catheters, stents, atherectomy catheters, aspirators, atrial isolators and perfusion catheters;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to compounds having a binding affinity for both the ?v?3 receptor and a (neuro)peptide receptor, in particular the somatostatin receptor, which compound comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, which second peptide part is a (neuro)peptide.